ATE520666T1 - Derivate von 18-amino-substituierten analoga des geldamycin-hydrochinons mit cyctotoxischer wirkung für die behandlung von krebs - Google Patents

Derivate von 18-amino-substituierten analoga des geldamycin-hydrochinons mit cyctotoxischer wirkung für die behandlung von krebs

Info

Publication number
ATE520666T1
ATE520666T1 AT07854639T AT07854639T ATE520666T1 AT E520666 T1 ATE520666 T1 AT E520666T1 AT 07854639 T AT07854639 T AT 07854639T AT 07854639 T AT07854639 T AT 07854639T AT E520666 T1 ATE520666 T1 AT E520666T1
Authority
AT
Austria
Prior art keywords
hydrocinone
geldamycin
cyctotoxic
cancer
derivatives
Prior art date
Application number
AT07854639T
Other languages
English (en)
Inventor
Chunlin Tao
Hongna Han
Xiaowen Sun
Neil Desai
Patrick Soon-Shiong
Original Assignee
Abraxis Bioscience Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abraxis Bioscience Llc filed Critical Abraxis Bioscience Llc
Application granted granted Critical
Publication of ATE520666T1 publication Critical patent/ATE520666T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D225/00Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/04Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D225/06Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT07854639T 2006-11-15 2007-11-14 Derivate von 18-amino-substituierten analoga des geldamycin-hydrochinons mit cyctotoxischer wirkung für die behandlung von krebs ATE520666T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86597706P 2006-11-15 2006-11-15
PCT/US2007/084662 WO2008061134A1 (en) 2006-11-15 2007-11-14 Derivatives of 18-amino substituted analogs of the geldamycin hydroquinon with cytotoxic activity for the treatment of cancer

Publications (1)

Publication Number Publication Date
ATE520666T1 true ATE520666T1 (de) 2011-09-15

Family

ID=39106113

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07854639T ATE520666T1 (de) 2006-11-15 2007-11-14 Derivate von 18-amino-substituierten analoga des geldamycin-hydrochinons mit cyctotoxischer wirkung für die behandlung von krebs

Country Status (11)

Country Link
US (1) US7816346B2 (de)
EP (1) EP2091919B1 (de)
AT (1) ATE520666T1 (de)
CA (1) CA2669820A1 (de)
CY (1) CY1112755T1 (de)
DK (1) DK2091919T3 (de)
ES (1) ES2367876T3 (de)
PL (1) PL2091919T3 (de)
PT (1) PT2091919E (de)
SI (1) SI2091919T1 (de)
WO (1) WO2008061134A1 (de)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3987035A (en) * 1974-04-05 1976-10-19 University Of Illinois Foundation Biologically active compounds
CA2146668A1 (en) * 1992-10-14 1994-04-28 Luke Whitesell Tumoricidal activity of benzoquinonoid ansamycins against prostate cancer and primitive neural malignancies
US6537579B1 (en) * 1993-02-22 2003-03-25 American Bioscience, Inc. Compositions and methods for administration of pharmacologically active compounds
US6096331A (en) * 1993-02-22 2000-08-01 Vivorx Pharmaceuticals, Inc. Methods and compositions useful for administration of chemotherapeutic agents
US5916596A (en) * 1993-02-22 1999-06-29 Vivorx Pharmaceuticals, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof

Also Published As

Publication number Publication date
EP2091919B1 (de) 2011-08-17
WO2008061134A1 (en) 2008-05-22
US20080234246A1 (en) 2008-09-25
EP2091919A1 (de) 2009-08-26
CY1112755T1 (el) 2016-02-10
DK2091919T3 (da) 2011-12-05
US7816346B2 (en) 2010-10-19
ES2367876T3 (es) 2011-11-10
CA2669820A1 (en) 2008-05-22
SI2091919T1 (sl) 2011-12-30
PT2091919E (pt) 2011-09-05
PL2091919T3 (pl) 2011-12-30

Similar Documents

Publication Publication Date Title
CY1122984T1 (el) Καρβαμιδικες ενωσεις και μεθοδοι παρασκευης και χρησης τους
MX2020002183A (es) Inhibidores de la ectonucleótido pirofosfatasa-fosfodiesterasa 1 (enpp-1) y usos de los mismos.
CY1123810T1 (el) Τριφθορομεθυλ υποκατεστημενα πυραζολια ως αναστολεις καλλικρεϊνης στο ανθρωπινο πλασμα
CY1121125T1 (el) Συνθεσεις για τη θεραπευτικη αντιμετωπιση του πονου και/ή της φλεγμονης
CY1123666T1 (el) Φαρμακευτικες ενωσεις
LTPA2016016I1 (lt) Azetinidai kaip mek inhibitoriai, skirti proliferacinių ligų gydymui
EA201690265A2 (ru) Фармацевтические композиции, содержащие замещенные ациланилиды
BR112015011497A2 (pt) composto, formulação farmacêutica, produto de combinação, e, método de tratamento de uma doença
MX2020011234A (es) Moduladores de receptor similar al dominio de oligomerizacion de union a nucleotidos que contiene dominio de pirina 3 (nlrp3).
GEP20237519B (en) Aza-heterobicyclic inhibitors of mat2a and methods of use for treating cancer
NO20091661L (no) Anvendelse av pegylert IL-10 for a behandle kreft
DK1519724T3 (da) Fredericamycin-derivater som lægemidler til behandling af tumorer
UA109878C2 (uk) Похідні ізохінолінону, фармацевтична композиція на їх основі (варіанти) та спосіб лікування захворювань (варіанти)
GEP20227443B (en) Magl inhibitors
EA201391720A1 (ru) Замещенные диоксопиперидинилфталимидные производные
EA200800555A1 (ru) Производные ксантина в качестве селективных агонистов hm74a
CY1125150T1 (el) Ενωσεις φαινυλο-2-υδροξυ-ακετυλαμινο-2-μεθυλο-φαινυλιου
DE50310516D1 (de) Fredericamycin-derivate
EA201001747A1 (ru) Бензоксазиноновые производные, действующие в качестве агониста бета-2-адренорецептора, для лечения респираторных расстройств
EA201001196A1 (ru) Соединения 4-пиридинона и их применение для лечения рака
MX2022006768A (es) Formulaciones/composiciones que comprenden un inhibidor de btk.
CY1116840T1 (el) Χρηση 24-norudca
EA201170344A1 (ru) Азаиндольные ингибиторы iap
CY1110027T1 (el) Συνδυασμος ενωσεων πυριμιδυλαμινοβενζαμιδης και ιματινιβης για τη θεραπεια ή την προληψη των νεοπλασματικων ασθενειων
MX2020011826A (es) Composiciones de combinacion que comprenden compuestos de bisfluoroalquil-1,4-benzodiazepinona y metodos de uso de las mismas.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2091919

Country of ref document: EP